Diatrizoate Meglumine and Diatrizoate Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-019
  • Package NDC 31722-019-31
  • Package NDC 31722-019-32
  • Application number ANDA215049
  • SPL ID 2e7917f2-e573-cccb-e063-6294a90a203c
  • SPL set ID a216a7d5-3c28-482b-956a-93ae146e3763
  • UNII 3X9MR4N98U
  • UNII V5403H8VG7

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
Diatrizoate Meglumine and Diatrizoate Sodium
Form
SOLUTION
Routes
ORAL, RECTAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-019_2e7917f2-e573-cccb-e063-6294a90a203c
{
  "name": "Diatrizoate Meglumine and Diatrizoate Sodium",
  "splId": "2e7917f2-e573-cccb-e063-6294a90a203c",
  "labels": [
    {
      "setId": "a216a7d5-3c28-482b-956a-93ae146e3763",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a216a7d5-3c28-482b-956a-93ae146e3763",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a216a7d5-3c28-482b-956a-93ae146e3763"
    }
  ],
  "routes": [
    "ORAL",
    "RECTAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "24 BOTTLE in 1 BOX (31722-019-31)  / 30 mL in 1 BOTTLE (31722-019-30)",
      "package_ndc": "31722-019-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231117"
    },
    {
      "sample": false,
      "description": "12 BOTTLE in 1 BOX (31722-019-32)  / 120 mL in 1 BOTTLE (31722-019-12)",
      "package_ndc": "31722-019-32",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231117"
    }
  ],
  "productId": "31722-019_2e7917f2-e573-cccb-e063-6294a90a203c",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "31722-019",
  "deaSchedule": null,
  "genericName": "Diatrizoate Meglumine and Diatrizoate Sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DIATRIZOATE MEGLUMINE",
      "strength": "660 mg/mL"
    },
    {
      "name": "DIATRIZOATE SODIUM",
      "strength": "100 mg/mL"
    }
  ],
  "applicationNumber": "ANDA215049",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20231117",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0331722019125",
      "0331722019309",
      "0331722019316"
    ],
    "unii": [
      "3X9MR4N98U",
      "V5403H8VG7"
    ],
    "spl_set_id": [
      "a216a7d5-3c28-482b-956a-93ae146e3763"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-019_2e7917f2-e573-cccb-e063-6294a90a203c"